﻿<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Vienna 2010 - bulletins</title>
    <description> </description>
    <link>http://www.aidsmap.com/Vienna-2010-bulletins/page/1446576/</link>
    <language>en-gb</language>
    <copyright>NAM Publications - 2012</copyright>
    <pubDate>Fri, 25 May 2012 01:32:49 GMT</pubDate>
    <lastBuildDate>Fri, 25 May 2012 01:32:49 GMT</lastBuildDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>RSS.NET: http://www.rssdotnet.com/</generator>
    <item>
      <title>Wednesday 28th July 2010 - English</title>
      <description>This is our final email bulletin covering the
International AIDS Conference in Vienna.
Visit www.aidsmap.com/vienna2010 for more
coverage. You can stay in touch with us all year round by signing up for one of our
regular email bulletins,
joining our Facebook network, contributing to our new E-atlas, or simply visiting our
website, aidsmap.com.
If you have found</description>
      <link>http://www.aidsmap.com/Wednesday-28th-July-2010-English/page/1498043/</link>
      <author>aidsmap.com</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/1498043/</guid>
      <pubDate>Wed, 28 Jul 2010 09:20:00 GMT</pubDate>
    </item>
    <item>
      <title>Friday 23rd July 2010 - English</title>
      <description>Images from presentation by Dr Cal
Cohen of Community Research Initiative New England (www.crine.org)Rilpivirine
(TMC278) is as effective as efavirenz (Sustiva
or Stocrin) when used in
combination antiretroviral therapy by people starting treatment, pooled results from two studies
presented to the Vienna conference show.
The safety
and effectiveness of rilpivirine,
an experimental non-nucleoside reverse transcriptase inhibitor (NNRTI), made</description>
      <link>http://www.aidsmap.com/Friday-23rd-July-2010-English/page/1496021/</link>
      <author>aidsmap.com</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/1496021/</guid>
      <pubDate>Fri, 23 Jul 2010 11:40:00 GMT</pubDate>
    </item>
    <item>
      <title>Wednesday 21st July 2010 - English</title>
      <description>Michel Kazatchkine, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. ©IAS/Steve Forrest/Workers' Photos.Increased access
to antiretroviral therapy in Brazil and South Africa has cut mortality rates,
but donor money to build on these successes internationally may be running short. 
Michel Kazatchkine of the Global Fund told the Vienna</description>
      <link>http://www.aidsmap.com/Wednesday-21st-July-2010-English/page/1494248/</link>
      <author>aidsmap.com</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/1494248/</guid>
      <pubDate>Wed, 21 Jul 2010 11:10:00 GMT</pubDate>
    </item>
    <item>
      <title>Thursday 22nd July 2010 - English</title>
      <description>Image from NAM's new E-atlas, online at www.aidsmap.com/e-atlasThere
was encouraging news at the conference about the pace of the HIV epidemic
amongst gay men in Denmark. But other research from Thailand and Brazil found a
high HIV incidence in some groups of men who have sex with men (MSM), and low
understanding of HIV</description>
      <link>http://www.aidsmap.com/Thursday-22nd-July-2010-English/page/1495902/</link>
      <author>aidsmap.com</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/1495902/</guid>
      <pubDate>Wed, 21 Jul 2010 11:10:00 GMT</pubDate>
    </item>
    <item>
      <title>Tuesday 20th July 2010 - English</title>
      <description>Prof. Quarraisha Abdool Karim, Associate Scientific Director of CAPRISA, explains how to use an applicator with gel. (Image: blogs.timeslive.co.za)A vaginal microbicide gel containing
the anti-HIV drug tenofovir (Viread)
reduces the risk of infection with HIV for women using it by 39%, results of a
study have shown. 
For women who used the
gel during</description>
      <link>http://www.aidsmap.com/Tuesday-20th-July-2010-English/page/1493072/</link>
      <author>aidsmap.com</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/1493072/</guid>
      <pubDate>Tue, 20 Jul 2010 10:20:00 GMT</pubDate>
    </item>
    <item>
      <title>Monday 19th July 2010 - English</title>
      <description>Image: ©IAS/Marcus 
Rose/Workers' PhotosThere was anger at the
opening of the 18th International AIDS Conference (AIDS 2010), being
held this week in Vienna, at the fact that donor nations aren’t keeping their
promises on HIV funding. 
Two thousand activists marched to the conference hall, and then occupied
the stage carrying a huge banner emblazoned</description>
      <link>http://www.aidsmap.com/Monday-19th-July-2010-English/page/1448166/</link>
      <author>aidsmap.com</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/1448166/</guid>
      <pubDate>Mon, 19 Jul 2010 10:40:00 GMT</pubDate>
    </item>
  </channel>
</rss>
